Cited 13 times in
Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이병완 | - |
dc.date.accessioned | 2023-08-22T07:18:10Z | - |
dc.date.available | 2023-08-22T07:18:10Z | - |
dc.date.issued | 2017-11 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/196110 | - |
dc.description.abstract | In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials have been introduced, and domestic data from studies performed in Korean patients with T2DM have been published. Recently, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations. Additionally, new data from clinical trials using dipeptidyl peptidase 4 inhibitors and thiazolidinediones in Korean patients with T2DM were added. Following a systematic review and assessment of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the use of antihyperglycemic agents and revised the treatment algorithm for Korean adult patients with T2DM. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | English | - |
dc.publisher | Korean Association of Internal Medicine | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Diabetes Mellitus, Type 2 / drug therapy* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hypoglycemic Agents / therapeutic use* | - |
dc.title | Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Seung-Hyun Ko | - |
dc.contributor.googleauthor | Kyu Yeon Hur | - |
dc.contributor.googleauthor | Sang Youl Rhee | - |
dc.contributor.googleauthor | Nan-Hee Kim | - |
dc.contributor.googleauthor | Min Kyong Moon | - |
dc.contributor.googleauthor | Seok-O Park | - |
dc.contributor.googleauthor | Byung-Wan Lee | - |
dc.contributor.googleauthor | Hyun Jin Kim | - |
dc.contributor.googleauthor | Kyung Mook Choi | - |
dc.contributor.googleauthor | Jin Hwa Kim | - |
dc.contributor.googleauthor | Committee of Clinical Practice Guideline of Korean Diabetes Association | - |
dc.identifier.doi | 10.3904/kjim.2017.298 | - |
dc.contributor.localId | A02796 | - |
dc.relation.journalcode | J02883 | - |
dc.identifier.eissn | 2005-6648 | - |
dc.identifier.pmid | 29056038 | - |
dc.subject.keyword | Diabetes mellitus, type 2 | - |
dc.subject.keyword | Hypoglycemic agents | - |
dc.subject.keyword | Insulin | - |
dc.subject.keyword | Practice guideline | - |
dc.contributor.alternativeName | Lee, Byung Wan | - |
dc.contributor.affiliatedAuthor | 이병완 | - |
dc.citation.volume | 32 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 947 | - |
dc.citation.endPage | 958 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, Vol.32(6) : 947-958, 2017-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.